BeStock  
Stocks › ARQT

Arcutis Biotherapeutics ARQT

US equityMarket cap rank #2441
$25.15 −$0.01 (-0.04%)
Pre-market · Oct 6, 7:40 am ET · After hours $25.25 +0.40%
Open$25.09
Prev close$25.16
Day range$24.69 – $25.39
Volume2.31M
Market cap$3.16B
P/E (TTM)114.3
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / book14.3x
CheapRich

Near the top of its 5-year range · 80th percentile, 5-year average 8.8x

#4991 of 5315 stocks by PB (1 = cheapest)

Morningstar fair value estimate

Fair value$20.75
Price vs. fair value+21.2%Trading above the estimate
Star rating★★★☆☆
Economic moatNarrow
UncertaintyHigh
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 14.33 – 8.81 80% (pricier than usual) #4991 of 5315 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Morningstar view

Star rating★★★
Fair value estimate$20.75
Economic moatNarrow
UncertaintyHigh

Discussion

No comments yet — be the first to weigh in on ARQT.

Leave a comment

Scroll to Top